University of Virginia
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1819-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.virginia.edu
Tuberculosis in Rural and Malnourished Populations
Not Applicable
Not yet recruiting
- Conditions
- Tuberculosis (TB)Undernutrition
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 360
- Registration Number
- NCT06971952
- Locations
- 🇹🇿
Haydom Lutheran Hospital, Haydom, Manyara, Tanzania
Inorganic Nitrate as a Treatment for ANOCA: NO-ANOCA
Not Applicable
Not yet recruiting
- Conditions
- Coronary Microvascular Dysfunction (CMD)Angina Patients With Non-obstructive Coronary Artery Disease
- First Posted Date
- 2025-04-29
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 8
- Registration Number
- NCT06948201
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Remote Resilience: Novel Applications of mHealth in Nicaragua's Cancer Control Program
Not Applicable
Not yet recruiting
- Conditions
- HPV InfectionCervical Cancers
- First Posted Date
- 2025-04-10
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 3000
- Registration Number
- NCT06921798
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Phase 3
Not yet recruiting
- Conditions
- Status Epilepticus
- Interventions
- Drug: Levetiracetam (LEV) (60 mg/Kg)Drug: Levetiracetam (LEV) (60 mg/Kg) + 1 mg/kg Ketamine (KET)Drug: Levetiracetam (LEV) (60 mg/Kg) + 3 mg/kg Ketamine (KET)
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 770
- Registration Number
- NCT06907173
Investigating the Cholinergic Contribution to Gait Dysfunction in Parkinson's Disease
- First Posted Date
- 2025-04-01
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 5
- Registration Number
- NCT06903910
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy
Not yet recruiting
- Conditions
- Obesity in ChildrenBone StrengthGLP - 1Lifestyle ModificationBone DensityObesity
- Interventions
- Drug: GLP-1 receptor agonistBehavioral: Lifestyle Management
- First Posted Date
- 2025-04-01
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 120
- Registration Number
- NCT06903923
- Locations
- 🇺🇸
University of Virginia Medical Center, Charlottesville, Virginia, United States
Clinical Validation of a Predictive Test for Postpartum Depression
Recruiting
- Conditions
- Postpartum Depression (PPD)Pregnancy
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 500
- Registration Number
- NCT06831968
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Early Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture
Not Applicable
Not yet recruiting
- Conditions
- Orthopedic DisorderHumerus FractureShoulder ArthroplastyReverse Shoulder Replacement
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 10
- Registration Number
- NCT06869343
- Locations
- 🇺🇸
University of Virginia Medical Center, Charlottesville, Virginia, United States
Smartphone-based Utility of the Vestibulo-ocular Reflex
- Conditions
- Vestibulo-Ocular Reflex (VOR) DysfunctionVestibular Function TestsVestibular Function DisordermHealth Application
- First Posted Date
- 2025-03-04
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 50
- Registration Number
- NCT06856746
- Locations
- 🇺🇸
University of Viginia, Charlottesville, Virginia, United States
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
Early Phase 1
Not yet recruiting
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Drug: Hyperpolarized Xe129
- First Posted Date
- 2025-02-28
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 6
- Registration Number
- NCT06853145
- Locations
- 🇺🇸
Snyder Building 480 Ray C. Hunt Drive, Charlottesville, Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath